About CervoMed
CervoMed (NASDAQ:CRVO) is a dynamic healthcare enterprise dedicated to innovating medical solutions for neurological disorders. The company operates through a wide array of products, including diagnostic equipment, therapeutic devices, and digital health platforms, aimed at enhancing patient care and outcomes in neurology. CervoMed is deeply invested in research and development, with ongoing projects focused on pioneering treatments for conditions such as epilepsy, Parkinson's disease, and migraines. Their objective is to improve the quality of life for patients living with neurologic conditions through advanced, accessible healthcare technologies. Passionately driven by a commitment to excellence and care, CervoMed continues to push the boundaries of medical science to meet the evolving needs of patients and healthcare providers worldwide.
Snapshot
Operations
Products and/or services of CervoMed
- Advanced Neurostimulation Devices for pain management, utilizing cutting-edge technology to offer non-invasive treatment options.
- Portable EEG Systems designed for real-time brain activity monitoring, enabling efficient diagnostics and research.
- Customized Neurofeedback Programs, offering tailored solutions for cognitive enhancement and rehabilitation.
- Telemedicine Services for neurological consultations, providing accessible care to patients remotely.
- Neuro-enhancement Devices, focused on improving cognitive functions and mental health through non-invasive therapies.
- Clinical Research Services, contributing to the development of innovative neurological treatment methodologies and devices.
CervoMed executive team
- Dr. John J. Alam M.D.Co-Founder, CEO, President & Director
- Dr. Sylvie L. Gregoire Pharm.D.Co-Founder & Director
- Mr. William Robert Elder J.D.CFO, General Counsel & Corporate Secretary
- Dr. Marinus Verwijs Ph.D.Executive Vice President of Technical Operations
- Ms. Kelly Blackburn M.H.A.Executive Vice President of Clinical Development
- Dr. Mark A. De Rosch Ph.D.Executive VP of Regulatory, Government Affairs & Program Management
- Dr. Claudia Ordonez M.D.Senior Vice President of Medical Science
- Dr. Matthew Winton Ph.D.Chief Commercial & Business Officer